|
|
|
|
|
|
|
|
January 30, 2012 — Long-term results from a brain tumor trial show that a chromosomal abnormality — 1p19q codeletion — plays a crucial role in the outcome of patients with oligodendrogliomas. The trial also demonstrates that codeleted tumors are profoundly chemosensitive........
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.